What you may need to know about PD – when you need to know it 



Simon Lewis on progress new antibody set to slow early stage PD

unnamedProfessor Simon Lewis reviews the press release reporting the 12 month data of the PASADENA study evaluating prasinezumab, new monoclonal antibody aiming to slowdisease progression in patients with early stage Parkinson’s Disease.